LUNG SQUAMOUS CELL CARCINOMA
Clinical trials for LUNG SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat cancers with genetic weakness
Disease control Recruiting nowThis study tests a new drug called TER-2013 in people with advanced solid tumors (like breast, endometrial, ovarian, lung, head and neck, esophageal, or cervical cancer) that have specific changes in the AKT/PI3K/PTEN pathway. The goal is to see if the drug is safe and shrinks tu…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Terremoto Biosciences Inc. • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
Radiation boosts immunotherapy in lung cancer fight?
Disease control Recruiting nowThis study tests whether adding low-dose radiation to standard immunotherapy and chemotherapy can shrink tumors better than standard treatment alone in people with advanced squamous cell lung cancer. About 114 participants will be randomly assigned to one of two groups. The goal …
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 17, 2026 00:45 UTC
-
New hope for advanced cancer: first human trial of JMT106 begins
Disease control Recruiting nowThis early-stage study tests a new drug called JMT106 in 200 adults with advanced solid tumors (such as lung or liver cancer) who have tried other treatments without success. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Parti…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC